Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.132 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.83NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCSNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KB.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CJ.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XANNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EU.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.277NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
AY.28 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.272NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.371NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.353NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.407NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.182NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.218NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.12.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.22 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.128NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used